A double-blind, randomized, placebo/active controlled crossover evaluation of the efficacy and safety of Ritalin ® LA in children with attention-deficit/hyperactivity disorder in a laboratory classroom setting.

@article{Schulz2010ADR,
  title={A double-blind, randomized, placebo/active controlled crossover evaluation of the efficacy and safety of Ritalin ® LA in children with attention-deficit/hyperactivity disorder in a laboratory classroom setting.},
  author={Eberhard Schulz and Christian Fleischhaker and Klaus Hennighausen and Philip Heiser and Klaus-Uwe Oehler and Martin Linder and Frank Walter H{\"a}\ssler and Michael Huss and Andreas Warnke and Martin Schmidt and Michael Schulte-Markworth and Christian Sieder and Jan Klatt and Ferenc Tracik},
  journal={Journal of child and adolescent psychopharmacology},
  year={2010},
  volume={20 5},
  pages={377-85}
}
OBJECTIVES The primary objective of this study was to demonstrate efficacy of Ritalin(®) LA 20 mg by showing superiority to placebo and noninferiority to Medikinet(®) Retard in a laboratory classroom setting. Secondary objectives included safety/tolerability and further efficacy parameters. METHODS A total of 147 children with attention-deficit/hyperactivity disorder (ADHD) diagnosed by the Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) and aged 6-14 (81% males) and known… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS
5 Citations
33 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 33 references

Similar Papers

Loading similar papers…